Kitanotatsujin Corp. (2930.T)
Tokyo, TK, JP
Kitanotatsujin Corporation plans, develops, manufactures, and sells health foods, cosmetics, and miscellaneous goods in Japan. It offers health foods and beauty products under the J North Farm brand. The company sell its products through online mail-order channel. Kitanotatsujin Corporation was founded in 2000 and is headquartered in Tokyo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.79% | +0.00% | -4.58% | -8.09% | -6.72% | -10.71% | -13.19% | -56.14% | -73.74% | +208.03% | +255.01% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Specialty Retail: +6.4%-5.2% Q1'26: +23.4% (vs Q1'25)
-
EPS growth Specialty Retail: +20.6%-42.4% Q1'26: -11.3% (vs Q1'25)
-
FCF margin FCF growth · Specialty Retail: +29.3%+8.3% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Specialty Retail: +5.4%+8.9% ★ Q1'26: +7.6% (vs Q1'25)
-
ROIC Specialty Retail: +6.5%+28.7% ★ Q1'26: +27.7% (vs Q1'25)
-
Share dilution Specialty Retail: +0.1%+0.1% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Specialty Retail: 0.14×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Feb 2019 actual |
Feb 2020 actual |
Feb 2021 actual |
Feb 2022 actual |
Feb 2023 actual |
Feb 2024 actual |
Feb 2025 actual |
Feb 2026 1 Rev. Ana. 1 EPS Ana. |
Feb 2027 1 Rev. Ana. 1 EPS Ana. |
Feb 2028 1 Rev. Ana. 1 EPS Ana. |
Feb 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.30B
est: 8.15B (+1.9%)
|
10.09B
est: 10.67B (-5.4%)
|
9.27B
est: 9.48B (-2.1%)
|
9.51B
est: 9.53B (-0.2%)
|
9.83B
est: 9.83B (+0.0%)
|
14.67B
est: 14.00B (+4.7%)
|
11.83B
est: 11.60B (+2.0%)
|
11.12B
11.12B – 11.12B
-4.1% YoY
|
15.80B
15.80B – 15.80B
+42.1% YoY
|
19.40B
19.40B – 19.40B
+22.8% YoY
|
22.70B
22.70B – 22.70B
+17.0% YoY
|
| EBITDA |
1.87B
est: 1.28B (+46.4%)
|
2.94B
est: 1.68B (+75.4%)
|
2.05B
est: 1.49B (+37.9%)
|
2.17B
est: 1.50B (+45.1%)
|
638.89M
est: 1.54B (-58.6%)
|
1.59B
est: 1.84B (-13.8%)
|
1.84B
est: 1.53B (+20.7%)
|
1.46B
1.46B – 1.46B
-4.1% YoY
|
2.08B
2.08B – 2.08B
+42.1% YoY
|
2.55B
2.55B – 2.55B
+22.8% YoY
|
2.99B
2.99B – 2.99B
+17.0% YoY
|
| EBIT |
1.86B
est: 1.20B (+54.9%)
|
2.92B
est: 1.57B (+85.4%)
|
2.03B
est: 1.40B (+45.4%)
|
2.08B
est: 1.40B (+48.2%)
|
510.15M
est: 1.45B (-64.8%)
|
1.45B
est: 1.68B (-13.8%)
|
1.68B
est: 1.39B (+20.2%)
|
1.34B
1.34B – 1.34B
-4.1% YoY
|
1.90B
1.90B – 1.90B
+42.1% YoY
|
2.33B
2.33B – 2.33B
+22.8% YoY
|
2.73B
2.73B – 2.73B
+17.0% YoY
|
| Net Income |
1.29B
est: 1.35B (-4.2%)
|
1.97B
est: 2.07B (-4.6%)
|
1.39B
est: 1.50B (-7.7%)
|
1.34B
est: 1.44B (-7.0%)
|
343.67M
est: 429.49M (-20.0%)
|
994.66M
est: 1.29B (-22.7%)
|
1.21B
est: 1.14B (+5.5%)
|
627.21M
627.21M – 627.21M
-45.1% YoY
|
752.65M
752.65M – 752.65M
+20.0% YoY
|
1.63B
1.63B – 1.63B
+116.7% YoY
|
2.17B
2.17B – 2.17B
+33.3% YoY
|
| SGA |
4.53B
est: 4.87B (-7.1%)
|
4.66B
est: 6.38B (-27.0%)
|
4.84B
est: 5.66B (-14.6%)
|
5.04B
est: 5.70B (-11.5%)
|
6.74B
est: 5.88B (+14.7%)
|
9.31B
est: 8.76B (+6.3%)
|
7.20B
est: 7.25B (-0.8%)
|
6.95B
6.95B – 6.95B
-4.1% YoY
|
9.88B
9.88B – 9.88B
+42.1% YoY
|
12.13B
12.13B – 12.13B
+22.8% YoY
|
14.20B
14.20B – 14.20B
+17.0% YoY
|
| EPS |
9.30
est: 9.70 (-4.1%)
|
14.21
est: 14.87 (-4.4%)
|
9.99
est: 10.80 (-7.5%)
|
9.66
est: 10.37 (-6.8%)
|
2.47
est: 3.09 (-19.9%)
|
7.15
est: 9.23 (-22.5%)
|
8.66
est: 8.20 (+5.6%)
|
4.50
4.50 – 4.50
-45.1% YoY
|
5.40
5.40 – 5.40
+20.0% YoY
|
11.70
11.70 – 11.70
+116.7% YoY
|
15.60
15.60 – 15.60
+33.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-28 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-27 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-26 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-25 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-22 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-21 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 3.1K | 0.30% |
| 2 | iShares Core TOPIX ETF 1475.T | 0.00% | 159.6K | 0.05% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Asako Horikawa | EVice President, Product and Customer Service Manager & Director | — | female |
| Katsuhisa Kinoshita | President, Web Marketing Manager & Representative Director | — | male |
| Kazuo Takahashi | Executive Officer & GM of Online Marketing Department | — | — |
| Maki Iimori | GM of HR & General Affairs Department and Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2930.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
